The investment seeks long-term growth of capital... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category SmallValue
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 47.85 | 0.57 | +1.21% |
SPDR® S&P Pharmaceuticals ETF | |||
XAIX | 39.02 | 0.05 | +0.13% |
Xtrackers Artfcl Intlgc and Big Dt ETF | |||
XIMR | 31.15 | 0.03 | +0.11% |
FT Vest U.S. Eq Buf & Prm Inc ETF - Mar | |||
POCT | 42.63 | N/A | N/A |
Innovator U.S. Equity Power Buf ETF™ Oct | |||
OEF | 321.66 | -1.03 | -0.32% |
iShares S&P 100 ETF |
A.I.dvisor indicates that over the last year, SCCVX has been closely correlated with DFFVX. These tickers have moved in lockstep 98% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCCVX jumps, then DFFVX could also see price increases.
Ticker / NAME | Correlation To SCCVX | 1D Price Change % | ||
---|---|---|---|---|
SCCVX | 100% | +0.36% | ||
DFFVX - SCCVX | 98% Closely correlated | +0.22% | ||
DFSVX - SCCVX | 98% Closely correlated | +0.20% | ||
VISVX - SCCVX | 97% Closely correlated | +0.42% | ||
VSIIX - SCCVX | 97% Closely correlated | +0.42% | ||
VSIAX - SCCVX | 97% Closely correlated | +0.42% | ||
More |